The Connection Between Dermatology and Joint Medicine: Exploring Skin and Joint Disorders
DOI:
https://doi.org/10.51699/ijhsms.v3i5.141Keywords:
Psoriatic arthritis, Skin and Joint Disorders, Symptoms, Health quality–life questionnaireAbstract
Psoriatic arthritis (PsA) is a chronic, systemic disease marked by joint and skin inflammation, significantly impacting patients' quality of life. This study aims to assess outcomes related to skin and joint disorders in PsA patients. Data were collected from 75 patients in various hospitals across Iraq between February 2023 and August 2024. Clinical outcomes, the EuroQol questionnaire (EQ-5D), Psoriatic Arthritis Impact of Disease (PsAID12), and the Work Productivity and Impairment Index (WPAI) were used to evaluate health status. Results showed that PsA primarily affects patients aged 56-65, with males (41) slightly outnumbering females (34). Obesity was prevalent in 30.67% of cases. Pain, fatigue, and skin issues were the most common symptoms. Pain scores averaged 17.64 ± 16.86 for skin and 25.36 ± 22.10 for joints. EQ-5D utility scores were 0.80 ± 0.16, and PsAID12 scores were 2.96 ± 1.97. The study concludes that PsA patients experience poor health outcomes, low quality of life, and reduced work productivity.
References
E. Christophers, J. N. Barker, C. E. Griffiths, et al., "The Risk of Psoriatic Arthritis Remains Constant Following the Initial Diagnosis of Psoriasis Among Patients Seen in European Dermatology Clinics," J. Eur. Acad. Dermatol. Venereol., vol. 24, no. 5, pp. 548–554, 2010.
C. T. Ritchlin, R. A. Colbert, and D. D. Gladman, "Psoriatic Arthritis," N. Engl. J. Med., vol. 376, no. 21, pp. 2095–2096, 2017.
L. C. Coates and P. S. Helliwell, "Psoriatic Arthritis: State of the Art Review," Clin. Med. (Lond), vol. 17, no. 1, pp. 65–70, 2017.
D. D. Gladman, V. Farewell, D. Buskila, et al., "Reliability of Measurements of Active and Damaged Joints in Psoriatic Arthritis," J. Rheumatol., vol. 17, no. 1, pp. 62–64, 1990.
N. J. McHugh, C. Balachrishnan, and S. M. Jones, "Progression of Peripheral Joint Disease in Psoriatic Arthritis: A 5-Year Prospective Study," Rheumatology (Oxford), vol. 42, no. 6, pp. 778–783, 2003.
P. J. Mease, C. J. Etzel, W. J. Huster, et al., "Understanding the Association Between Skin Involvement and Joint Activity in Patients with Psoriatic Arthritis: Experience from the Corrona Registry," RMD Open, vol. 5, no. 1, p. e000867, 2019.
J. F. Merola, D. Shrom, J. Eaton, et al., "Patient Perspective on the Burden of Skin and Joint Symptoms of Psoriatic Arthritis: Results of a Multi-National Patient Survey," Rheumatol. Ther., vol. 6, no. 1, pp. 33–45, 2019.
C. F. Rosen, F. Mussani, V. Chandran, et al., "Patients with Psoriatic Arthritis Have Worse Quality of Life Than Those with Psoriasis Alone," Rheumatology (Oxford), vol. 51, no. 3, pp. 571–576, 2012.
F. Salaffi, M. Carotti, S. Gasparini, et al., "The Health-Related Quality of Life in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis: A Comparison with a Selected Sample of Healthy People," Health Qual. Life Outcomes, vol. 7, p. 25, 2009.
H. Zachariae, R. Zachariae, K. Blomqvist, et al., "Quality of Life and Prevalence of Arthritis Reported by 5,795 Members of the Nordic Psoriasis Associations: Data from the Nordic Quality of Life Study," Acta Derm. Venereol., vol. 82, no. 2, pp. 108–113, 2002.
J. A. Husted, D. D. Gladman, V. T. Farewell, and R. J. Cook, "Health-Related Quality of Life of Patients with Psoriatic Arthritis: A Comparison with Patients with Rheumatoid Arthritis," Arthritis Rheum., vol. 45, no. 2, pp. 151–158, 2001.
K. de Vlam, J. F. Merola, J. A. Birt, et al., "Skin Involvement in Psoriatic Arthritis Worsens Overall Disease Activity, Patient-Reported Outcomes, and Increases Healthcare Resource Utilization: An Observational Cross-Sectional Study," Rheumatol. Ther., vol. 5, no. 2, pp. 423–436, 2018.
P. J. Mease, C. Karki, J. B. Palmer, et al., "Clinical and Patient-Reported Outcomes in Patients with Psoriatic Arthritis (PsA) by Body Surface Area Affected by Psoriasis: Results from the Corrona PsA/Spondyloarthritis Registry," J. Rheumatol., vol. 44, no. 8, pp. 1151–1158, 2017.
N. Kamalaraj, C. El-Haddad, P. Hay, and K. Pile, "Systematic Review of Depression and Anxiety in Psoriatic Arthritis," Int. J. Rheum. Dis., vol. 22, no. 6, pp. 967–973, 2019.
A. R. Moverley, K. A. Vinall-Collier, and P. S. Helliwell, "It’s Not Just the Joints, It’s the Whole Thing: Qualitative Analysis of Patients’ Experience of Flare in Psoriatic Arthritis," Rheumatology (Oxford), vol. 54, no. 8, pp. 1448–1453, 2015.
A. R. Moverley, R. Waxman, M. de Wit, et al., "Development of a Flare Instrument for Use in Psoriatic Disease: A Report from the 2015 GRAPPA Annual Meeting," J. Rheumatol., vol. 43, no. 5, pp. 974–978, 2016.
P. Anderson, M. Benford, N. Harris, et al., "Real-World Physician and Patient Behaviour Across Countries: Disease-Specific Programmes—A Means to Understand," Curr. Med. Res. Opin., vol. 24, no. 11, pp. 3063–3072, 2008.
P. Dolan, "Modeling Valuations for EuroQol Health States," Med. Care, vol. 35, no. 11, pp. 1095–1108, 1997.
EuroQol Group, "EuroQol—A New Facility for the Measurement of Health-Related Quality of Life," Health Policy, vol. 16, no. 3, pp. 199–208, 1990.
M. C. Reilly, A. S. Zbrozek, and E. M. Dukes, "The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument," Pharmacoeconomics, vol. 4, no. 5, pp. 353–365, 1993.
W. Tillett, C. Y. Lin, A. Zbrozek, et al., "A Threshold of Meaning for Work Disability Improvement in Psoriatic Arthritis Measured by the Work Productivity and Activity Impairment Questionnaire," Rheumatol. Ther., 2019.
J. F. Fries, P. Spitz, R. G. Kraines, and H. R. Holman, "Measurement of Patient Outcome in Arthritis," Arthritis Rheum., vol. 23, no. 2, pp. 137–145, 1980.
J. F. Fries, P. W. Spitz, and D. Y. Young, "The Dimensions of Health Outcomes: The Health Assessment Questionnaire, Disability and Pain Scales," J. Rheumatol., vol. 9, no. 5, pp. 789–793, 1982.
L. Gossec, M. de Wit, U. Kiltz, et al., "A Patient-Derived and Patient-Reported Outcome Measure for Assessing Psoriatic Arthritis: Elaboration and Preliminary Validation of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire, a 13-Country EULAR Initiative," Ann. Rheum. Dis., vol. 73, no. 6, pp. 1012–1019, 2014.
A. M. Orbai and A. Ogdie, "Patient-Reported Outcomes in Psoriatic Arthritis," Rheum. Dis. Clin. North Am., vol. 42, no. 2, pp. 265–283, 2016.
W. H. Boehncke, R. Horvath, E. Dalkilic, et al., "Association Between Clinical Specialty Setting and Disease Management in Patients with Psoriatic Arthritis: Results from LOOP, a Cross-Sectional, Multi-Country, Observational Study," J. Eur. Acad. Dermatol. Venereol., 2020.
M. E. Husni, A. Fernandez, B. Hauber, et al., "Comparison of US Patient, Rheumatologist, and Dermatologist Perceptions of Psoriatic Disease Symptoms: Results from the DISCONNECT Study," Arthritis Res. Ther., vol. 20, no. 1, p. 102, 2018.
A. Kavanaugh, A. Gottlieb, A. Morita, et al., "The Contribution of Joint and Skin Improvements to the Health-Related Quality of Life of Patients with Psoriatic Arthritis: A Post Hoc Analysis of Two Randomized Controlled Studies," Ann. Rheum. Dis., vol. 78, no. 9, pp. 1215–1219, 2019.
A. Kavanaugh, I. B. McInnes, G. G. Krueger, et al., "Patient-Reported Outcomes and the Association with Clinical Response in Patients with Active Psoriatic Arthritis Treated with Golimumab: Findings Through 2 Years of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial," Arthritis Care Res. (Hoboken), vol. 65, no. 10, pp. 1666–1673, 2013.
